ANI Pharmaceuticals, Inc. (ANIP)

NASDAQ: ANIP · Real-Time Price · USD

72.18

-0.78 (-1.07%)

At close: Oct 2, 2026, 4:00 PM EDT

72.76

+0.58 (0.80%)

After-hours: Oct 2, 2026, 7:30 PM EDT

ANI Pharmaceuticals Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	978.38	883.37	614.38	486.82	316.39	216.14
Revenue Growth	30.90%	43.78%	26.20%	53.87%	46.38%	3.67%
Gross Profit	590.98	542.06	377.77	305.3	177.6	115.53
Operating Income	123.6	83.33	33.92	49.53	-25.73	-28.17
Net Income	99.6	70.22	-20.15	15.48	-49.52	-42.79
Earnings Per Share	4.54	3.32	-1.04	0.85	-3.05	-3.40
EPS Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Generics and Other	412.06	399.43	320.03	289.31	235.24
Rare Disease and Brands	566.32	483.93	294.34	197.5	81.15
Total	978.38	883.37	614.38	486.82	316.39

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	376.96	294.72	151.17	221.12	48.23	100.3
Total Debt	626.03	628.28	624.09	285.67	287.9	287.37
Net Cash (Debt)	-249.07	-333.57	-472.92	-64.55	-239.67	-187.07
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-11.30	-15.71	-24.48	-3.55	-14.74	-14.85

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	189.47	185.23	64.02	118.96	-31.2	3.32
Capital Expenditures	-16.48	-13.84	-16.24	-8.87	-8.88	-2.56
Free Cash Flow	172.99	171.39	47.78	110.09	-40.08	0.77
Free Cash Flow Growth	37.90%	258.70%	-56.60%	-	-	-91.62%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	60.40%	61.36%	61.49%	62.71%	56.13%	53.45%
Operating Margin	12.63%	9.43%	5.52%	10.17%	-8.13%	-13.03%
Pretax Margin	14.57%	10.84%	-3.62%	4.08%	-19.81%	-25.94%
Profit Margin	10.18%	7.95%	-3.28%	3.18%	-15.65%	-19.80%
FCF Margin	17.68%	19.40%	7.78%	22.61%	-12.67%	0.35%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	15.90	23.50	-	68.00	-	-
Forward PE	7.73	10.03	10.72	14.04	14.79	12.86
P/FCF Ratio	8.94	9.63	22.59	9.56	-	1008.43
PS Ratio	1.58	1.87	1.76	2.16	2.07	3.57